Betacellulin enhances ovarian cancer cell migration by up-regulating Connexin43 via MEK-ERK signaling.
@article{Zhao2019BetacellulinEO, title={Betacellulin enhances ovarian cancer cell migration by up-regulating Connexin43 via MEK-ERK signaling.}, author={Jianfang Zhao and Christian Klausen and Yuyin Yi and Jung-Chien Cheng and Hsun‐Ming Chang and Peter C. K. Leung}, journal={Cellular signalling}, year={2019}, pages={ 109439 } }
3 Citations
Betacellulin promotes tumor development and EGFR mutant lung cancer growth by stimulating the EGFR pathway and suppressing apoptosis
- Biology, MedicineiScience
- 2022
Sitagliptin Modulates the Response of Ovarian Cancer Cells to Chemotherapeutic Agents
- BiologyInternational journal of molecular sciences
- 2020
The obtained data showed that sitagliptin used with paclitaxel may be considered as a possibility of pharmacological modulation of intracellular transmission pathways to improve the response to chemotherapy.
Connexins in Cancer: Jekyll or Hyde?
- BiologyBiomolecules
- 2020
It is proposed that connexins function upstream of most, if not all, of the hallmarks of cancer and the development of advanced connexin targeting approaches remains an opportunity for the field to further interrogate the role of con Nexins in cancer phenotypes.
References
SHOWING 1-10 OF 29 REFERENCES
Betacellulin induces Slug-mediated down-regulation of E-cadherin and cell migration in ovarian cancer cells
- BiologyOncotarget
- 2016
The results suggest that betacellulin induces ovarian cancer migration and Slug-dependent E-cadherin down-regulation via EGFR-mediated MEK-ERK and PI3K-Akt signaling.
Transforming growth factor-β stimulates human ovarian cancer cell migration by up-regulating connexin43 expression via Smad2/3 signaling.
- Biology, ChemistryCellular signalling
- 2015
EGF‐Induced Connexin43 Negatively Regulates Cell Proliferation in Human Ovarian Cancer
- Biology, MedicineJournal of cellular physiology
- 2016
It is demonstrated that treatment with EGF upregulates Cx43 expression in two ovarian cancer cell lines, SKOV3 and OVCAR4, and reveals an important role for Cx 43 as a negative regulator of EGF‐induced human ovarian cancercell proliferation.
Connexins as targets for cancer chemoprevention and chemotherapy.
- BiologyBiochimica et biophysica acta
- 2005
Expression of betacellulin and epidermal growth factor receptor in hepatocellular carcinoma: implications for angiogenesis.
- Biology, MedicineHuman pathology
- 2006
Role of connexins in metastatic breast cancer and melanoma brain colonization
- BiologyJournal of Cell Science
- 2013
Evidence is provided that breast cancer and melanoma cells utilize connexin gap junction proteins (Cx43, Cx26) to initiate brain metastatic lesion formation in association with the vasculature and that connexins might be exploited therapeutically to benefit cancer patients with metastatic disease.
Gap junctional intercellular communication and connexin43 expression in human ovarian surface epithelial cells and ovarian carcinomas in vivo and in vitro.
- Biology, MedicineCarcinogenesis
- 1999
Gap junctional intercellular communication (GJIC) and the expression of gap junction proteins (connexins) are frequently decreased in neoplastic cells and have been increased by cAMP and retinoids, but both agents inhibited cell growth.
Expression of erbB-4/HER-4 growth factor receptor isoforms in ovarian cancer.
- BiologyCancer research
- 2001
The use of an anti-erbB4 blocking antibody suggested that erbB4 was not the mediator of the growth stimulatory effects of neuregulin in ovarian cancer cells and indeed could potentially antagonize this effect.
Connexin43 Expression Increases in the Epithelium and Stroma along the Colonic Neoplastic Progression Pathway: Implications for Its Oncogenic Role
- Medicine, BiologyGastroenterology research and practice
- 2011
Cx43 cytoplasmic expression was relatively increased in the adenocarcinoma at the invasive tumor front in all stages and may play a critical role in the pathogenesis of colon cancer via gap junction or other gap junction independent mechanisms such as the Wnt/β-catenin pathway.
Increased concentrations of growth factors and activation of the EGFR system in breast cancer
- Medicine, BiologyClinical chemistry and laboratory medicine
- 2012
HER2, HB-EGF, TGFα and AREG were upregulated in cancer tissue as compared with autologous reference tissue while EGFR, pEGFR and EGF were downregulated and a profound activation of the EGFR system was demonstrated.